🇺🇸

US SEC Filing Intelligence

· daily

General Federal Contracts — September 25, 2026

This digest covers $2.59 billion in federal contracts awarded between 2014 and 2026, with zero defense-related awards—all are civilian, dominated by the Department of Commerce (Census Bureau) and the Department of Veterans Affairs. The highest-conviction signal is TriWest Healthcare Alliance Corp.'s $1.2 billion VA contract, a bullish award that underscores strong demand for healthcare administration services. However, three of four contracts are expired or nearing expiration, creating significant revenue uncertainty for MAXIMUS, Guidehouse Digital, and General Dynamics IT. Key risk: the $911 million MAXIMUS Census contract ended in 2021 with no follow-on, pressuring future earnings.

4 total filings
· daily

S&P 500 Technology Sector SEC Filings — September 25, 2026

The S&P 500 Technology sector is exhibiting a clear divergence between management confidence and capital return. While Oracle and Marvell are signaling stability through predictable governance and a modest dividend, a significant insider selling event at Broadcom, coupled with smaller sales at Fortinet and Datadog, creates a bearish undercurrent. The aggregate insider activity reveals over $87M in stock sales by key executives and directors, largely executed under Rule 10b5-1 plans, which mitigates immediate alarm but flags potential overvaluation or portfolio rebalancing at the top. The sector shows no aggressive capital deployment through buybacks or special dividends, and forward-looking guidance is absent from these filings, creating a data vacuum that heightens the importance of upcoming earnings calls. The primary actionable intelligence lies in monitoring Broadcom's insider selling pattern for further liquidation and preparing for the Oracle AGM as a potential catalyst for governance-related volatility.

5 high priority 1 medium 6 total filings
· daily

Nasdaq 100 Stocks SEC Filings — September 25, 2026

Today's NASDAQ-100 digest is dominated by two themes: a major insider sell-off at Broadcom and a series of administrative filings from Strategy Inc. Broadcom director Samueli Henry executed a massive, pre-planned sale of over $81 million in stock, a bearish signal that warrants close monitoring for further insider liquidation. Strategy Inc filed three documents, including a proposal to shift four preferred stock series to daily dividend record dates, a logistical change that does not alter total payout amounts but may signal a strategic shift in capital management. The remaining filings (Qualcomm Form 4 and two Strategy proxy statements) are low-materiality administrative items. No period-over-period comparisons or forward-looking guidance changes were available in this batch, limiting trend analysis. The key takeaway is the concentrated insider selling at Broadcom, which could indicate a peak valuation view by a key insider, and the operational fine-tuning at Strategy Inc, which may be a precursor to more aggressive capital allocation.

2 high priority 3 medium 5 total filings
· daily

US Activist Hedge Fund Institutional SEC 13D 13G — September 25, 2026

The 31 filings reveal a surge in activist and strategic stake-building, with Tessenderlo Group's 20% private placement in FMC Corp and Byron Allen's 55.7% controlling stake in BuzzFeed as the most material events. Insider trading patterns show significant accumulation in TORM plc (Hafnia Ltd adding $202.9M in two weeks) and Redwood Trust (Howard Amster group investing $46M), while Carl Icahn's routine dividend distribution and the Dondero entities' small DRIP purchases indicate passive maintenance. Period-over-period comparisons highlight a notable dilution event at Jin Medical International, where CEO Erqi Wang's economic stake fell from 6.77% to 3.35% due to share issuance for an acquisition, though he retains 96.15% voting control. The Grayscale Near Trust filing shows a rapid in-and-out trade, with Karminski acquiring 8.04% then selling down to 2.61% within the same period. Overall, the digest points to concentrated activist positioning in undervalued assets (FMC, BuzzFeed, TORM), passive institutional accumulation in SPACs and biotech, and a few exit filings from completed mergers or dilution events.

17 high priority 14 medium 31 total filings
· daily

S&P 500 Financials Sector SEC Filings — September 25, 2026

The session was extremely quiet with only two filings from the S&P 500 Financials sector, both representing low-materiality events. CME Group executed a routine capital structure cleanup by eliminating its Series G preferred stock, a non-event with no financial impact. The only significant signal came from Aflac, where 10% owner Japan Post Holdings sold approximately $1.56 million in shares under a pre-arranged 10b5-1 plan, registering as a notable insider divestiture from a major strategic holder. There are no period-over-period trends to aggregate across filings due to the lack of operational or financial data. The key takeaway is the absence of material developments, but the Aflac insider sale warrants monitoring for potential follow-through or a broader strategic shift by Japan Post.

2 high priority 2 total filings
· daily

S&P 500 Energy Sector SEC Filings — September 25, 2026

The five filings in this digest, all from S&P 500 Energy constituents, reveal a sector focused on corporate governance, capital structure optimization, and management continuity rather than operational performance. Texas Pacific Land Corp (TPL) dominates the filing flow with three corporate actions: a proxy statement proposing redomestication to Texas, executive contract extensions through 2029, and a minor insider buy by a 10% owner. ExxonMobil's debt issuance of $185.9M in 50-year floating rate notes signals opportunistic low-rate lock-in, though the small size relative to its balance sheet suggests routine treasury management. No period-over-period financial comparisons were available in any filing, limiting trend analysis, but the absence of negative guidance or insider selling is a modest positive. The sector theme centers on governance efficiency (redomestication, meeting date changes) and long-term capital planning, with no immediate operational catalysts. Investors should monitor TPL's redomestication vote (Nov 5, 2026) and ExxonMobil's debt market activity for broader credit signals.

3 high priority 2 medium 5 total filings
· daily

S&P 500 Consumer Staples Sector SEC Filings — September 25, 2026

The seven filings for the Consumer Staples stream are all Form 4 insider ownership filings from The Clorox Company, representing a coordinated, company-wide equity grant to top executives. This cluster of filings, all dated September 25, 2026, reveals a significant and uniform insider accumulation event totaling over $4.3 million in stock awards across the C-suite. The pattern of awards—proportional to executive seniority—is a strong signal of management alignment and a bullish indicator for the company's long-term strategy. With no sales or option exercises reported, the sentiment is unequivocally positive. This event stands out as a high-conviction signal in a sector where insider buying is often a leading indicator of management confidence. The lack of any other filing types (e.g., 10-K, 8-K) in this batch limits the ability to perform cross-company period-over-period comparisons, but the depth of insider data provides a powerful, singular theme for the digest.

7 high priority 7 total filings
· daily

S&P 500 Industrials Sector SEC Filings — September 25, 2026

The two filings from the S&P 500 Industrials stream reveal contrasting insider sentiment within the defense and logistics sub-sectors. A director at FedEx executed a large stock option exercise and subsequent tax withholding, indicating a neutral, non-cash event with no new market signal. In stark contrast, a director at General Dynamics sold nearly all of his holdings after a stock option exercise, realizing a significant gain and leaving a minimal residual stake. This divergence highlights a potential risk flag for General Dynamics, as the near-complete liquidation by a board member may signal a lack of confidence in near-term valuation or outlook. No period-over-period financial trends, forward-looking guidance, or capital allocation data were available in these filings, limiting the scope of cross-company synthesis to insider activity patterns.

2 high priority 2 total filings
· daily

US Material Events SEC 8-K Filings — September 25, 2026

This batch of 50 filings reveals a market bifurcated between aggressive capital deployment and operational distress. A clear theme is the significant capital market activity, with several companies issuing substantial debt ($1B by DICK'S Sporting Goods, $2.28B by CleanSpark, C$1.5B by Sysco) to fund growth, acquisitions, or refinancing, signaling a 'growth-at-scale' mindset in sectors like data centers and retail. Conversely, a cluster of companies (SOBR Safe, Sadot Group, Feel The World) are in acute distress, marked by discontinued operations, auditor dismissals due to internal control weaknesses, and financial restatements, creating a stark 'haves vs. have-nots' landscape. Leadership transitions are widespread, with 10+ filings announcing C-suite or board changes, though most appear orderly. A notable positive outlier is Worthington Enterprises, which reported a 13% YoY sales increase driven by the booming data center liquid cooling market, while The Hartford Insurance Group realized a massive $497M pre-tax gain from a reinsurance commutation. The most actionable intelligence lies in tracking the execution of the large-scale debt-funded strategies and monitoring the distressed companies for potential restructuring or dissolution events.

50 high priority 50 total filings
· daily

Insider Trading Pulse — September 25, 2026

The September 25, 2026, insider trading digest reveals a market characterized by significant insider selling at elevated valuations, particularly in the technology and energy sectors, while routine director and executive stock awards dominate the filing volume. A notable cluster of high-value, pre-planned sales by C-suite officers at Fastly, Redwire, and Credo Technology signals potential profit-taking or hedging at perceived peaks, with aggregate insider sales exceeding $20 million. Conversely, a bullish insider purchase by Skillsoft's CEO provides a contrarian signal in a distressed company. The data shows a clear bifurcation: routine equity grants and tax-withholding transactions are neutral, while discretionary sales by top executives at high-growth tech firms and energy directors warrant closer scrutiny. The absence of significant forward-looking guidance changes or capital allocation shifts in the filings limits the ability to forecast near-term catalysts, but the sheer volume of 10b5-1 plan sales suggests a cautious stance among insiders at current market levels.

50 high priority 50 total filings
· daily

Dow Jones 30 Stocks SEC Filings — September 25, 2026

This session was exceptionally quiet for the Dow 30, with only one filing from Walt Disney Co (a Form 4 ownership report) that lacked any substantive enriched data due to retrieval issues. The filing carries neutral sentiment and low materiality, offering no actionable period-over-period trends, insider transaction details, forward-looking guidance, or capital allocation signals. As a result, no portfolio-level patterns or sector themes can be derived from this single, data-deficient entry. Investors should note the absence of material developments across the index, suggesting a period of low volatility or reporting lull. The key takeaway is that no actionable intelligence emerged from this filing, and the session provides no basis for trade signals or risk adjustments.

1 high priority 1 total filings
· daily

US Corporate Distress Financial Stress SEC Filings — September 25, 2026

This intelligence brief reveals a severe and concentrated wave of corporate distress across US-listed companies, with 8 out of 10 filings detailing active delisting threats or non-compliance with exchange listing standards. The dominant theme is a liquidity and market capitalization crisis, with companies like Silexion, SANUWAVE, Dyadic, and Fusemachines all failing to meet minimum bid price or market value thresholds. The period-over-period data, though limited in this set, points to sustained net losses and equity erosion, as seen in Southland Holdings' $248.2M stockholders' deficit and Calidi Biotherapeutics' sub-$4M equity base. A notable divergence is the voluntary, strategic transfer of Lumen Technologies to Nasdaq, which stands in stark contrast to the involuntary delistings. Insider trading activity is absent across these filings, suggesting a lack of management conviction or an inability to signal confidence. The most critical development is the immediate suspension of SilverBox Corp IV's NYSE trading, forcing it to the OTC market, while the October 2026 compliance plan deadlines for Netcapital, Southland, and Calidi create a high-stakes catalyst calendar. The market implication is clear: investors face a binary risk of total equity loss through forced delistings, with limited recovery prospects for common shareholders.

10 high priority 10 total filings
· daily

Global High-Priority Regulatory Events — September 25, 2026

This digest covers 42 filings, predominantly centered on a wave of Nasdaq and NYSE delisting threats, insolvency proceedings, and SPAC activity. The most critical theme is the cluster of 8+ companies facing imminent delisting for failing to meet minimum bid price, market value, or equity requirements, signaling severe financial distress across small-cap and pre-revenue biotech/tech sectors. A secondary theme is the surge in Indian insolvency and open offer activity, including the NCLT approval of Dabur India's Sesa Care merger and the rejection of a settlement proposal for Vas Infrastructure, highlighting a bifurcation between successful restructuring and deadlocked resolutions. SPAC filings show mixed signals: while Paramount Skydance and NMP Acquisition Corp. advance their mergers, SilverBox Corp IV and Inflection Point Acquisition Corp. V have been delisted, underscoring the high failure rate in the de-SPAC pipeline. Tender offers from closed-end funds like BlackRock Alpha Strategies and Ares Strategic Income Fund indicate a trend of managed liquidity events, though low take-up rates in several A&Q funds suggest limited investor appetite. The overall sentiment is negative, with 15+ filings carrying negative sentiment and materiality scores of 8/10 or higher, concentrated in delisting and insolvency risks.

42 high priority 42 total filings
· daily

US SEC Filings Daily Market Digest — September 25, 2026

Today's filings reveal a market bifurcated between high-stakes corporate actions (mergers, asset sales, activist stakes) and routine governance updates. Key themes include significant M&A and restructuring activity (VerifyMe/OpenWorld merger, Titan International's $285M divestiture, Quality Industrial's complex share exchange), activist investor positioning (Jewett Cameron 13D filing), and leadership transitions at major firms (Monster Beverage, Circle, Nextdoor). Period-over-period data is sparse, but forward-looking statements highlight major catalysts: Elroy Air's $175M PIPE and Army contract, Tamboran's first gas sales, and Pulmatrix's reverse merger. Insider activity is mostly routine grants, but a notable director sale at Cypherpunk Technologies ($662K) and a large insider award at Janus International ($750K retention RSUs) stand out. The overall sentiment is cautiously optimistic, with several 'mixed' filings reflecting the uncertainty inherent in pending deals and restructurings.

42 high priority 8 medium 50 total filings
· daily

S&P 500 Healthcare Sector SEC Filings — September 25, 2026

The two filings for the S&P 500 Healthcare stream reveal a quiet period with no financial results or forward guidance, but significant corporate actions and insider activity. The dominant theme is Medtronic's high-materiality separation of its MiniMed diabetes business, a major strategic pivot that will reshape the company's portfolio and unlock shareholder value. In contrast, Abbott Laboratories shows a routine, non-discretionary insider transaction from a director, which carries low signaling value but confirms compliance with standard equity compensation practices. The absence of period-over-period financial data or guidance in either filing limits trend analysis, but the Medtronic spin-off presents a clear catalyst for portfolio rebalancing and relative value trades within the healthcare sector. Overall, the digest points to a focus on corporate restructuring and passive insider activity, with no immediate sector-wide themes emerging from the limited data set.

2 high priority 2 total filings
· daily

US Earnings Financial Results SEC Filings — September 25, 2026

This batch of 21 filings reveals a bifurcated market: a cluster of pre-revenue development-stage companies (Niocorp, Tamboran, SunHydrogen, Propanc, Incannex) are burning cash aggressively while successfully raising capital, creating a high-risk/high-reward dynamic. Conversely, mature operators like Donaldson and Home Federal Bancorp show steady, profitable growth. A notable theme is the prevalence of 'mixed' sentiment (15 of 21 filings), indicating widespread uncertainty. Key period-over-period trends include significant margin compression in manufacturing (Integrated BioPharma) and retail (Cracker Barrel), while energy-related trusts (Marine Petroleum, Amplify) face volume and asset value declines. The most critical development is the severe cash burn and negative equity at CID Holdco, which presents an imminent risk of failure. Portfolio-level patterns suggest a capital-intensive shift towards critical minerals and energy transition, with companies successfully raising large equity rounds despite widening losses.

21 high priority 21 total filings
· daily

US Executive Compensation Proxy SEC Filings — September 25, 2026

The 13 proxy filings reveal a period of significant corporate transformation, with a pronounced shift toward non-traditional value-creation strategies. A clear theme is the use of corporate actions—including reverse mergers, Bitcoin treasury strategies, and redomestication—to unlock shareholder value or address liquidity challenges, often with mixed governance implications. The filings show a bifurcation between stable, well-governed entities like Oracle and Greene County Bancorp, and high-risk, transformative plays at Pulmatrix, Super League, and Lifeward. Period-over-period comparisons are limited in the proxy data, but insider activity and capital allocation decisions provide actionable signals. The most critical developments include the proposed Metaplanet Bitcoin investment at Super League, the reverse merger at Pulmatrix, and the take-private of Weave Communications, each carrying distinct risk/reward profiles for investors.

13 high priority 13 total filings
· daily

US IPO Pipeline SEC S-1 Filings — September 25, 2026

The IPO pipeline for September 25, 2026, reveals a bifurcated market: one traditional operating company (Interpace Biosciences) seeking to raise capital amid severe operational distress, one blank-check company (TCGX Acquisition Corp. II) launching a standard SPAC IPO, and one business combination filing (Snowdrift Parent Corp / Chemomab Therapeutics) reflecting the ongoing de-SPAC trend. Period-over-period trends are limited as these are initial registration statements, but the filings collectively signal a cautious but active market for equity capital formation. Interpace's S-1 highlights a company in crisis—post-Nasdaq delisting, reliant on a single customer, and with no near-term product pipeline—while TCGX's SPAC IPO represents a pure-play bet on management's ability to find a target within 24 months. The Chemomab/Snowdrift combination underscores persistent capital needs in the biotech sector, with Chemomab showing continued operating losses and reliance on multiple financing rounds. The most critical development is Interpace's attempt to go public despite severe headwinds, which may test investor appetite for high-risk, micro-cap diagnostics. Portfolio-level patterns include a lack of insider buying in any filing, signaling management caution, and a reliance on external capital (SPACs, follow-ons) rather than organic growth.

3 high priority 3 total filings
· daily

US SEC Trading Suspension Halt Orders — September 25, 2026

This intelligence stream reveals a concentrated wave of trading suspensions and delisting threats across US exchanges, primarily Nasdaq and NYSE, with 9 of 10 filings representing newly published distress signals. The dominant theme is the failure to maintain minimum market capitalization and bid price requirements, with 5 companies (Silexion, Dyadic, SANUWAVE, Fusemachines, SilverBox Corp IV) facing delisting for breaching these thresholds. A secondary cluster involves financial reporting non-compliance (Netcapital) and sustained net losses eroding stockholders' equity (Southland Holdings, Calidi Biotherapeutics). Notably, two companies—Paramount Skydance Corp and Lumen Technologies—are voluntarily transferring listings to NYSE and Nasdaq, respectively, signaling strategic repositioning rather than distress. The aggregate picture shows a tightening regulatory environment where small-cap and micro-cap companies are particularly vulnerable, with compliance deadlines clustering between October 2026 and March 2028. Insider trading data and forward-looking statements are sparse across these filings, but the absence of insider buying in the face of existential delisting risk is itself a bearish signal. The most critical development is SilverBox Corp IV's immediate trading suspension and forced migration to OTC, representing a total loss of exchange liquidity for its shareholders.

10 high priority 10 total filings
· daily

US Executive Officer Management Changes SEC — September 25, 2026

This digest of 36 filings reveals a period of significant leadership transition across US equities, with CEO changes at AllianceBernstein and CoreCivic, CFO departures at Circle and Stark Focus Group, and multiple C-suite and board appointments. The most material event is the planned retirement of AllianceBernstein's CEO Seth Bernstein, a high-impact succession with a $13.5M compensation package for the incoming CEO, signaling an orderly but costly transition. CoreCivic's CEO resignation due to health reasons is a high-materiality event, though the internal promotion of a seasoned executive mitigates immediate risk. A notable cluster of COO departures is observed across three BlackRock-affiliated funds (Private Credit, Direct Lending, TCP Capital) and BitGo, all citing pursuit of other opportunities, suggesting a potential sector-wide talent reshuffling in asset management and crypto. Worthington Enterprises stands out with strong operational performance (13% YoY sales growth) and a bullish data center cooling catalyst, while Janus International's restructuring signals operational strain despite projected cost savings. Overall, the period is characterized by orderly successions and board refreshments, with no widespread negative trends, but the concentration of departures in asset management warrants monitoring for further instability.

36 high priority 36 total filings